4-(Piperidin-4-yl)pyridine hydrochloride, 97%, 10g

1,3,6,8-Tetraethynyl-9H-carbazole, 97%, 1g

anti-Keratin K19 mouse monoclonal, Ks19.2 (Z105.6), 1 ml

2-methoxy-N-methyl-4-{9-methyl-3,9-diazaspiro[5.5]undecan-3-yl}aniline, 97.0%, 500mg

N-Methyl-4-methoxybenzimine, 95.0%, 25g

Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate, 97%, 250mg

3-(Aminomethyl)bicyclo[1.1.1]pentane-1-carbonitrile hydrochloride, 98%, 250mg

N-(4-Nitrophenylsulfonyl)-L-phenylalanine>98.0%(T)5g

11-(2-Chloroacetyl)-5H-benzo[e]pyrido[3,2-b][1,4]diazepin-6(11H)-one, 99.0%, 10g

Tetrahydrofuran (stabilized with BHT)>99.5%(GC)25mL

2-Trifluoroacetylphenol, 95.0%, 250mg

dimethyl sulfoxide D6, 99.9 at%D, 7.5 ml, glass packagingamp.

3-Chloro-2-methoxy-4-(trifluoromethyl)pyridine, 95.0%, 250mg